FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 51 filers reported holding FORTRESS BIOTECH INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $469,000 | +42.1% | 175,000 | 0.0% | 0.27% | +8.8% |
Q1 2020 | $330,000 | -35.8% | 175,000 | -12.5% | 0.25% | +57.9% |
Q4 2019 | $514,000 | +82.3% | 200,000 | 0.0% | 0.16% | +84.9% |
Q3 2019 | $282,000 | +39.6% | 200,000 | +48.4% | 0.09% | +43.3% |
Q2 2019 | $202,000 | – | 134,757 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 315,000 | $1,433,000 | 0.41% |
CPWM, LLC | 171,049 | $778,000 | 0.12% |
HighPoint Advisor Group LLC | 21,777 | $393,000 | 0.11% |
Bryn Mawr Capital Management, LLC | 17,961 | $82,000 | 0.07% |
Spark Investment Management LLC | 94,700 | $430,000 | 0.03% |
B. Riley Wealth Advisors, Inc. | 37,621 | $171,000 | 0.02% |
ClariVest Asset Management LLC | 122,619 | $558,000 | 0.01% |
DENVER INVESTMENT ADVISORS LLC | 20,413 | $93,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 50,170 | $228,000 | 0.00% |
Virtu Financial LLC | 15,311 | $70,000 | 0.00% |